期刊文献+

重复经颅磁刺激治疗帕金森病后抑郁的疗效观察 被引量:9

Observation of repetitively transcranial magnetic stimulation in the treatment of depression induced by Parkinson's disease
暂未订购
导出
摘要 目的观察重复经颅磁刺激(rTMS)对帕金森病(PD)后抑郁的临床疗效。方法将我院收治的68例PD后抑郁的患者随机分为2组,对照组给予常规抗PD治疗药物,治疗组在对照组治疗基础上联合rTMS治疗,采用汉密尔顿抑郁量表(HAMD)及统一帕金森病评定量表(UPDRS)对治疗前后2组患者抑郁状态及生活、运动功能进行对比。记录治疗组患者rTMS治疗的不良反应。结果治疗组治疗前后HAMD及UPDRS评分显著降低;治疗组HAMD评分较对照组显著降低(P<0.05);治疗组不良反应轻微。结论 rTMS治疗PD后抑郁安全有效,值得临床推广。 Objective To explore the clinical effect of low-frequency repetitive transcranial magnetic stimulation(rTMS) in the treatment of depression induced by Parkinson's disease. Methods Sixty-eight patients with depression patients induced by PD were randomly divided into two groups, 32 patients were enrolled as control group, with the average age of(64.72± 6.03) years old including 18 males and 16 females, and 36 patients were performed as treatment group, with the average age of(66.08 ± 6.2.5) years old including 19 males and 17 females. The control group patients received conventional anti-Parkinson therapy. In addition to conventional anti-Parkinson therapy, treatment group patients were given low-frequency rTMS treatment for 2 weeks. The Hamilton depression rating scale (HAMD) and the unified Parkinson's disease rating scale(UPDRS) were com- pared between the two groups before and after treatment. The side effects of rTMS were also recorded. Results After 2 weeks of treatment, the treatment group had significantly lower HAMI) scores and UPDRS scores than before treatment, and the av- erage HAMD scores of treatment group were significantly lower than control group. There was no obvious difference in HAMD scores of control group before and after treatment. Two patients of treatment group had a transient headache while reducing the stimulus intensity of rTMS. Conclusion Low-frequency rTMS is a safe and effective treatment for depression induced by Par- kinson' s disease.
出处 《中国实用神经疾病杂志》 2012年第16期11-13,共3页 Chinese Journal of Practical Nervous Diseases
关键词 重复经颅磁刺激 帕金森病 抑郁症 Repetitively transcranial magnetic stimulation(rTMS) Parkinson' s disease Depression
  • 相关文献

参考文献9

二级参考文献59

  • 1陈生弟.帕金森病治疗指南[J].中华神经科杂志,2006,39(6):409-412. 被引量:103
  • 2温洪波,张振馨,罗毅,陈生弟,蒋雨平,张小英,孙相如,王新德,姚晨.普拉克索治疗帕金森病的多中心、随机、双盲、溴隐亭对照临床疗效和安全性研究[J].中华神经科杂志,2006,39(9):604-608. 被引量:63
  • 3王新德.帕金森病及帕金森综合征的诊断标准和鉴别诊断[J].中华神经精神科杂志,1985,18(4):256-256.
  • 4Parkinson Study Group. Effects of tocopherol and deprenyl on the progression of disability in early Parkinson' s disease. N Engl J Med, 1993, 328 : 176-183.
  • 5Hauser RA, Lew MF, Hurtig HI, et al. Long-term outcome of early versus delayed rasagiline treatment in early Parkinson' s disease. Mov Disord, 2008, 24:562-571.
  • 6Bonuccelli U, Pavese N. Role of dopamine agonists in Parkinson' s disease : an update. Expert Rev Neurother, 2007, 7 : 1391-1399.
  • 7Shults CW, Oakes D, Kieburtz K, et al. Effects of coenzyme Q10 in early Parkinson disease: evidence of slowing of the functional decline. Arch Neurol, 2002, 59 : 1541-1550.
  • 8Albin RL, Frey KA. Initial agonist treatment of Parkinson disease : a critique. Neurology, 2003, 60 : 390-394.
  • 9Olanow W, Schapira AH, Rascol O. Continuous dopamine- receptor stimulation in early Parkinson' s disease. Trends Neurosci, 2000, 23 ( 10 Suppl) : Sl17-126.
  • 10Olanow CW, Watts RL, Koller WC. An algorithm ( decision tree) for the management of Parkinson' s disease ( 2001 ) : treatment guidelines. Neurology, 2001,56 ( 11 Suppl 5 ) : S1-S88.

共引文献240

同被引文献87

引证文献9

二级引证文献95

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部